Skip to main content

Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease

A flurry of regulatory announcements relating to COVID treatments, vaccines and boosters dominated headlines on the pandemic Friday, with Europe now considering giving vaccines full marketing authorization to avoid having to review them every year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.